ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2013

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,801Medicare Part D Prescriptions Filled, Including Refills

Rank: 85 out of 1226

$457K Total Retail Price of All Prescriptions

Rank: 271 out of 1226

349 Patients Receiving at Least One Drug in Part D
53% Patients 65 Years and Older
95% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg 81928cdb0ebe162ff75cf405bfacadd396bf3ec84bc467b6f3e612dd63daa776 Average for
this specialty
in New Jersey
Lower avg 72b1978e1dcc0b845f89d17d692cfff7aeaf8d8bce70310d8bfc535db2daf62a

Schedule Two
Controlled Substances

4% of this provider’s 349 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

5% of this provider’s 349 patients filled at least one prescription for a schedule three drug, compared to an average of 4%.

Brand Name Drugs

23% of this provider’s prescriptions were for brand-name drugs, compared to an average of 27%.

Prescription Price

$47 was the average price of a prescription from this provider, compared to $78 among peers.

Prescriptions per Patient

28 is the average number of prescriptions (including refills) per patient, compared to an average of 14.


This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

B

A benzodiazepine, or tranquilizer. More » The American Geriatrics Society says these drugs increase the risk of cognitive impairment, delirium, falls and fractures in older adults.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled with Refills Prescriptions
to 65+
Patients Recieving this Drug Category For this Prescriber For All Prescribers in
This Specialty in New Jersey
OMEPRAZOLE 561 367 102 1 6
SIMVASTATIN 492 336 83 2 1
METFORMIN HCL 473 290 79 3 7
LISINOPRIL 426 267 77 4 5
AMLODIPINE BESYLATE 308 214 49 5 2
HYDROCHLOROTHIAZIDE 236 188 46 6 9
IBUPROFEN 219 130 69 7 62
LEVOTHYROXINE SODIUM 215 146 31 8 3
METOPROLOL TARTRATE 213 140 38 9 10
PROAIR HFA 181 118 52 10 42
GABAPENTIN 163 96 37 11 22
NAPROXEN 154 95 68 12 71
GLIPIZIDE 150 106 24 13 76
ZOLPIDEM TARTRATE 145 77 31 14 16
RANITIDINE HCL 137 75 27 15 73
LANTUS 137 83 28 15 94
ATORVASTATIN CALCIUM 126 84 26 17 4
NEXIUM 123 68 23 18 19
LISINOPRIL-HYDROCHLOROTHIAZIDE 121 85 26 19 45
ATENOLOL 121 64 16 19 21
CARVEDILOL 119 83 21 21 20
ADVAIR DISKUS 111 59 23 22 43
GEMFIBROZIL 110 85 22 23 198
CLOPIDOGREL 104 77 19 24 15
LOSARTAN-HYDROCHLOROTHIAZIDE 95 39 17 25 52
LOSARTAN POTASSIUM 94 71 17 26 17
PAROXETINE HCL 93 57 20 27 79
MONTELUKAST SODIUM 91 41 13 28 37
PRAVASTATIN SODIUM 90 56 20 29 13
METOPROLOL SUCCINATE 89 49 14 30 11
DONEPEZIL HCL 83 65 13 31 31
VENTOLIN HFA 81 42 27 32 104
FLUTICASONE PROPIONATE 80 39 31 33 28
FLOVENT HFA 79 49 24 34 204
DIOVAN 79 54 13 34 24
FUROSEMIDE 76 64 21 36 8
CLONIDINE HCL 73 24 12 37 77
TAMSULOSIN HCL 71 54 15 38 30
GLIMEPIRIDE 71 <11 <11 38 33
BUSPIRONE HCL 70 35 22 40 150
ALENDRONATE SODIUM 69 64* 11 41 40
CILOSTAZOL 68 56 12 42 276
ENALAPRIL MALEATE 66 52 14 43 32
AZITHROMYCIN 64 39 48 44 34
SERTRALINE HCL 64 30 16 44 23
HUMALOG 60 20 11 46 175
MECLIZINE HCL 58 41 19 47 102
ALPRAZOLAM 51 46* 12 B 48 12
VALSARTAN-HYDROCHLOROTHIAZIDE 50 34 12 49 47
About This Data

Prescribing data from Medicare’s prescription drug benefit, known as Part D, was compiled and released by the Centers for Medicare and Medicaid Services, the federal agency that oversees the program. ProPublica combined that data with additional information released by CMS. The data for 2013 includes nearly 1.4 billion prescriptions written by 1.3 million doctors, nurses and other providers. This database lists about 410,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths of these prescriptions went to patients 65 and older; the rest were for disabled patients Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to checkup@propublica.org and we will update your information. If you have other questions about this data, send a note to checkup@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 9, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.